Wnt signaling activation and mammary gland hyperplasia in MMTV–LRP6 transgenic mice: implication for breast cancer tumorigenesis (original) (raw)

• Amundadottir LT, Merlino G, Dickson RB . (1996). Transgenic mouse models of breast cancer. Breast Cancer Res Treat 39: 119–135.
  Article CAS PubMed Google Scholar
• Bafico A, Gazit A, Wu-Morgan SS, Yaniv A, Aaronson SA . (1998). Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene 16: 2819–2825.
  Article CAS PubMed Google Scholar
• Bafico A, Liu G, Goldin L, Harris V, Aaronson SA . (2004). An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6: 497–506.
  Article CAS PubMed Google Scholar
• Bartkova J, Lukas J, Müller H, Lützhøft D, Strauss M, Bartek J . (1994). Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57: 353–361.
  Article CAS PubMed Google Scholar
• Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA . (2006). Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis. Cancer Res 66: 2691–2699.
  Article CAS PubMed Google Scholar
• Bu G, Geuze HJ, Strous GJ, Schwartz AL . (1995). 39-kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J 14: 2269–2280.
  Article CAS PubMed PubMed Central Google Scholar
• Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968–988.
  Article CAS PubMed Google Scholar
• Chenard MP, Lutz Y, Mechine-Neuville A, Stoll I, Bellocq JP, Rio MC et al. (1999). Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas. Int J Cancer 82: 208–212.
  Article CAS PubMed Google Scholar
• Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P et al. (1999). The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883–2891.
  Article CAS PubMed Google Scholar
• Deming SL, Nass SJ, Dickson RB, Trock BJ . (2000). C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 83: 1688–1695.
  Article CAS PubMed PubMed Central Google Scholar
• Egeblad M, Werb Z . (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161–174.
  Article CAS PubMed Google Scholar
• Giles RH, van Es JH, Clevers H . (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1–24.
  CAS PubMed Google Scholar
• Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C et al. (1994). Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812–1817.
  CAS PubMed Google Scholar
• He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
  Article CAS PubMed Google Scholar
• Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH . (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273–282.
  CAS PubMed PubMed Central Google Scholar
• Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F . (2002). Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172–1183.
  Article CAS PubMed PubMed Central Google Scholar
• Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G et al. (2004). Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol 25: 641–649.
  CAS PubMed Google Scholar
• Lane TF, Leder P . (1997). Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Oncogene 15: 2133–2144.
  Article CAS PubMed Google Scholar
• Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S et al. (2002). Activation of AXIN2 expression by β-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 277: 21657–21665.
  Article CAS PubMed Google Scholar
• Li Y, Lu W, He X, Schwartz AL, Bu G . (2004). LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering β-catenin subcellular distribution. Oncogene 23: 9129–9135.
  Article CAS PubMed Google Scholar
• Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y et al. (2000). β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262–4266.
  Article CAS PubMed PubMed Central Google Scholar
• Lindvall C, Evans NC, Zylstra CR, Li Y, Alexander CM, Williams BO . (2006). The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem 281: 35081–35087.
  Article CAS PubMed Google Scholar
• Lindvall C, Bu W, Williams BO, Li Y . (2007). Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev 3: 157–168.
  Article CAS PubMed Google Scholar
• Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, Furge KA et al. (2009). The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS One 4: e5813.
  Article PubMed PubMed Central Google Scholar
• Lu W, Kim KA, Liu J, Abo A, Feng X, Cao X et al. (2008). R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression. FEBS Lett 582: 643–650.
  Article CAS PubMed Google Scholar
• Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U et al. (2002). Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184–1193.
  Article CAS PubMed PubMed Central Google Scholar
• McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD et al. (1995). Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11: 885–891.
  CAS PubMed Google Scholar
• Moon RT, Kohn AD, De Ferrari GV, Kaykas A . (2004). WNT and β-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691–701.
  Article CAS PubMed Google Scholar
• Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN . (1993). ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci USA 90: 8977–8981.
  Article CAS PubMed PubMed Central Google Scholar
• Nass SJ, Dickson RB . (1997). Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44: 1–22.
  Article CAS PubMed Google Scholar
• Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Danø K . (1997). Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab Invest 77: 345–355.
  CAS PubMed Google Scholar
• Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR et al. (2001). Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 61: 7091–7100.
  CAS PubMed Google Scholar
• Nusse R, Varmus HE . (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99–109.
  Article CAS PubMed Google Scholar
• Nusse R, van Ooyen A, Cox D, Fung YK, Varmus H . (1984). Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307: 131–136.
  Article CAS PubMed Google Scholar
• Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P et al. (1995). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92: 2730–2734.
  Article CAS PubMed PubMed Central Google Scholar
• Peters G, Brookes S, Smith R, Dickson C . (1983). Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell 33: 369–377.
  Article CAS PubMed Google Scholar
• Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC . (2000). An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407: 535–538.
  Article CAS PubMed Google Scholar
• Rodriguez S, Jafer O, Goker H, Summersgill BM, Zafarana G, Gillis AJ et al. (2003). Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 22: 1880–1891.
  Article CAS PubMed Google Scholar
• Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. (1999). The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522–5527.
  Article CAS PubMed PubMed Central Google Scholar
• Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW et al. (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137–146.
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y . (2002). Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861–5867.
  Article CAS PubMed Google Scholar
• Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y et al. (2000). LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530–535.
  Article CAS PubMed Google Scholar
• Tamamura Y, Otani T, Kanatani N, Koyama E, Kitagaki J, Komori T et al. (2005). Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280: 19185–19195.
  Article CAS PubMed Google Scholar
• Tetsu O, McCormick F . (1999). β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 39: 422–426.
  Article Google Scholar
• Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE . (1988). Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619–625.
  Article CAS PubMed Google Scholar
• Turashvili G, Bouchal J, Burkadze G, Kolar Z . (2006). Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 73: 213–223.
  Article CAS PubMed Google Scholar
• Ugolini F, Charafe-Jauffret E, Bardou VJ, Geneix J, Adelaide J, Labat-Moleur F et al. (2001). WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 20: 5810–5817.
  Article CAS PubMed Google Scholar
• Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV . (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671.
  Article CAS PubMed Google Scholar
• Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D et al. (2000). arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature 407: 527–530.
  Article CAS PubMed Google Scholar
• Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP et al. (1993). Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90: 1843–1847.
  Article CAS PubMed PubMed Central Google Scholar
• Wu B, Crampton SP, Hughes CC . (2007). Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26: 227–239.
  Article CAS PubMed PubMed Central Google Scholar
• Yan D, Wiesman M, Rohan M, Chan V, Jefferson AB, Guo L et al. (2001). Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA 98: 14973–14978.
  Article CAS PubMed PubMed Central Google Scholar